Classys Q1 2026: Revenue KRW 87.2B, Operating Profit KRW 37.2B; Enhanced Shareholder Returns via Dividend Hike and Share Cancellation

Consolidated Q1 2026: Revenue KRW 87.2B (est. +26% YoY), Operating Profit KRW 37.2B (OPM 42.7%), Net Profit KRW 33.6B
EPS: KRW 515; FY2025 dividend raised to KRW 1,000/share (from KRW 257, +289%)
Cancellation of 270,000 treasury shares in February 2026 (treasury shares reduced from 352,170 to 15,964)
Acquired JL Health (Brazil, 77.5% stake) and 2 entities in Argentina and Colombia (100% stake), increasing consolidated subsidiaries to 11
Overseas sales accounted for 73% (KRW 63.6B); direct sales expansion in Brazil and Japan
Allowance for bad debts surged to KRW 44.5B (26.5% of receivables), mainly due to M&A and overseas expansion
Increased borrowings in multiple currencies (BRL, JPY, COP) from local banks for Brazilian subsidiaries
R&D investment of KRW 5.0B (5.8% of revenue); IP portfolio: 1,268 registered, 2,025 pending
One pending litigation (KRW 438M claim); various guarantees and collateral agreements
Largest shareholder BCPE Centur stake decreased to 46.1% (from 54.2%), potential block sale risk

ADVERTISEMENT (250px+)